HOME ABOUT OPEN PRAIRIE TEAM ENTREPRENEURS PORTFOLIO         Harvesting Efficient InnovationTM
 Portfolio

 
KCBioMediX

KCBioMediX

This medical device company was established to commercialize technologies developed at the University of Kansas that measure, develop and monitor the Non-Nutritive Suck (“NNS”). NNS is an essential building block in an infant’s development of the coordinated sucking, breathing and swallowing capability needed in independent oral feeding. The inability to feed independently is the leading cause of failure to discharge from the hospital for premature babies.

cpac

Compact Particle Acceleration Corporation

The company is partnering with TomoTherapy Incorporated and the Lawrence Livermore National Laboratory (LLNL) to create the next generation of compact proton therapy for cancer treatment.  The key component of the new technology is a dielectric wall accelerator (DWA) that was developed through research conducted at the LLNL.  The DWA will allow CPAC to produce an intensity modulated proton therapy (IMPT) machine that can be used in a standard therapy treatment room.  While particle therapy has been shown to be a superior form of cancer treatment, cost is a significant barrier.  Current proton therapy technology is performed in massive three-story facilities can most millions to build, thus there are only 25 such centers worldwide.  The proposed CPAC system will carry a significant lover initial cost, allowing CPAC the opportunity to make IMPT available to a broader range of hospitals and cancer centers.  In addition to cancer treatment, the technology has the potential to be used in other fields such as defense, security and semiconductors. 

 

iCyt

iCyt

iCyt is a firm with considerable depth of expertise in the field of flow cytometry, the science of cell measurement.  Operating from a state-of-the-art 45,000 square foot facility adjacent to the University of Illinois at Urbana-Champaign, iCyt has been recognized repeatedly as one of the most desirable employers in the state of Illinois.  iCyt offers a comprehensive line of flow cytometry products, including the revolutionary Reflection™ cell sorter, popular Lyt laser system, lab productivity software, and novel reagent solutions. A leading innovator in the industry, iCyt has received the Frost & Sullivan Emerging Technology Award, the Milestone Award, and the Entrepreneurial Excellence Award, in recognition of its contribution to technological development.

 


Vestaron

Vestaron (formerly known as Venomix) is developing proprietary agriculture insecticide products for the environmentally conscious twenty-first century. The target markets of agricultural, specialty non-crop, and animal health have a combined value of $15 billion, providing the company with significant opportunity across multiple venues for product development and commercialization. The core technology for Vestaron is based on the utilization of polypeptides found in spider venom. These compounds have unique modes of action and target sites within the insects that are not currently targeted by existing insecticide products. Preliminary tests have produced positive results against a variety of insects and pest species including mosquitoes, caterpillars, house flies and cockroaches. Additionally, Vestaron products are designed to be harmless to non-target species, including humans and other mammals.


Infoblox

Infoblox develops and markets a task-specific server appliance offering a more effective approach to Domain Name Service (DNS) and Dynamic Host Configuration Protocol (DHCP). The design and application of DNS/DHCP solutions in the past have been resource intensive and have opened networks to security breaches, outages and downtime. The flagship product is a server appliance provides reliable, secure enterprise-class DNS/DHCP service in a streamlined product. The product is the DNS/DHCP solution of choice for the Networld+Interop's networks, eNet and iLabs, some of the most advanced networks in the world.

 


EpiWorks

Develops and manufactures advanced compound wafers for a variety of semiconductor applications such as medical and industrial lasers, wireless and fiber optic communications chips, and optical communication components. The core technology and competency is based on providing advanced Gallium Arsenide (GaAs) and Indium Phosphide (InP) compound semiconductor materials with complete semiconductor solutions combining both materials technology and applications expertise to advance the product performance.

 


Cernium

The Company develops proprietary software integrating computer systems for industry-specific electronic security solutions using video technology. The software solutions are used in multiple applications from government to commercial and from industrial to institutional. The core direction is toward the creation of industry-specific products focusing on intelligent image analysis via closed circuit television monitoring systems. Cernium is a pioneer in advanced video analysis for physical security. Our breakthrough solutions identify suspicious or unusual behavior through video analysis, helping achieve clients security and fiscal objectives by improving the efficiency and effectiveness of their entire security operation.

 


ISSI/Argus Systems

Also known as Argus, has software technology converting a Unix-based operating system into a Trusted Operating System (TOS). A TOS is a government-defined system for making an operating system extremely secure. They have products for several high-end operating systems, including IBM's AIX, Sun Microsystems' Solaris, and most commercial versions of Linux.

 

INVESTMENT HIGHLIGHT

MedVenture

MedVenture is a premier medical-device solutions company, providing a broad-base of global medical device companies with a fully integrated design, development and manufacturing resource model emphasizing on complex cardiovascular, neurosurgical, urological and general surgery medical device technologies.

Sold September 2008

 

MedVenture Logo

  

TomoTherapy

TomoTherapy began May 9, 2007 trading on the NASDAQ stock exchange under the symbol TOMO for $19.00 per share.

NASDAQ: TOMO



  

iNest Realty

The ecommerce real estate investment was sold by the Fund in the fourth quarter of 2004 in a cash-sale transaction
to Lending Tree, a division of IAC.

EXIT

Sold to InterActive Corp (NASD: IAC)


  

 

HOME | ABOUT OPEN PRAIRIE | TEAM | ENTREPRENEURS | PORTFOLIO | NEWS | CONTACT US | LEGAL | INVESTOR ACCESS